SE408709B - Forfarande for framstellning av indol-, resp azaindol merkatoforeningar - Google Patents

Forfarande for framstellning av indol-, resp azaindol merkatoforeningar

Info

Publication number
SE408709B
SE408709B SE7407175A SE7407175A SE408709B SE 408709 B SE408709 B SE 408709B SE 7407175 A SE7407175 A SE 7407175A SE 7407175 A SE7407175 A SE 7407175A SE 408709 B SE408709 B SE 408709B
Authority
SE
Sweden
Prior art keywords
markato
azaindol
resp
indol
compounds
Prior art date
Application number
SE7407175A
Other languages
English (en)
Other versions
SE7407175L (sv
Inventor
V P Arya
K Nagarajan
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of SE7407175L publication Critical patent/SE7407175L/xx
Publication of SE408709B publication Critical patent/SE408709B/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/06Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D239/08Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms directly attached in position 2
    • C07D239/10Oxygen or sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/16Otologicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
SE7407175A 1973-06-14 1974-05-30 Forfarande for framstellning av indol-, resp azaindol merkatoforeningar SE408709B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH860973A CH574441A5 (sv) 1973-06-14 1973-06-14

Publications (2)

Publication Number Publication Date
SE7407175L SE7407175L (sv) 1974-12-16
SE408709B true SE408709B (sv) 1979-07-02

Family

ID=4342576

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7407175A SE408709B (sv) 1973-06-14 1974-05-30 Forfarande for framstellning av indol-, resp azaindol merkatoforeningar

Country Status (17)

Country Link
US (1) US3954757A (sv)
JP (1) JPS5849557B2 (sv)
AT (1) AT333267B (sv)
BE (1) BE816262A (sv)
CH (1) CH574441A5 (sv)
DD (1) DD112132A5 (sv)
DE (1) DE2427207A1 (sv)
DK (1) DK142701B (sv)
ES (1) ES427269A1 (sv)
FR (1) FR2233047B1 (sv)
IE (1) IE39495B1 (sv)
IL (1) IL44876A (sv)
LU (1) LU70309A1 (sv)
MC (1) MC1036A1 (sv)
NL (1) NL7407614A (sv)
SE (1) SE408709B (sv)
YU (1) YU164774A (sv)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5038759B2 (sv) * 1971-12-20 1975-12-11
US4055647A (en) * 1973-06-14 1977-10-25 Ciba-Geigy Corporation Condensed pyrrole mercapto compounds having hypotensive and decongestant properties
BE503170A (sv) * 1975-09-02
US3996218A (en) * 1975-09-08 1976-12-07 E. R. Squibb & Sons, Inc. Oxopyridazinylthiomethyl derivatives of ureidocephalosporins
US4171367A (en) * 1977-02-18 1979-10-16 Abbott Laboratories Pyrazolyl amino imidazolines
US5486525A (en) * 1993-12-16 1996-01-23 Abbott Laboratories Platelet activating factor antagonists: imidazopyridine indoles
US7582651B2 (en) * 2002-07-11 2009-09-01 Takeda Pharmaceutical Company Limited Pyrrolopyridine derivative and use thereof
CA2797281A1 (en) * 2010-05-06 2011-11-10 Merck Sharp & Dohme Corp. Aza-indole derivatives useful as modulators of faah

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1141949A (en) * 1966-02-23 1969-02-05 Sterling Drug Inc 7-azaindole derivatives
US3377247A (en) * 1967-04-28 1968-04-09 Dow Chemical Co Antidepressant method
US3586695A (en) * 1968-01-26 1971-06-22 Dow Chemical Co Substituted imidazolinyl indoles

Also Published As

Publication number Publication date
DK142701B (da) 1980-12-22
CH574441A5 (sv) 1976-04-15
BE816262A (fr) 1974-12-13
IE39495B1 (en) 1978-10-25
FR2233047A1 (sv) 1975-01-10
NL7407614A (sv) 1974-12-17
DK316674A (sv) 1975-02-17
DE2427207A1 (de) 1975-01-09
YU164774A (en) 1982-08-31
DD112132A5 (sv) 1975-03-20
ATA484774A (de) 1976-03-15
LU70309A1 (sv) 1976-04-13
SE7407175L (sv) 1974-12-16
ES427269A1 (es) 1976-07-01
MC1036A1 (fr) 1975-05-30
IL44876A0 (en) 1974-07-31
US3954757A (en) 1976-05-04
IL44876A (en) 1978-01-31
DK142701C (sv) 1981-09-21
JPS5849557B2 (ja) 1983-11-05
FR2233047B1 (sv) 1977-11-04
AT333267B (de) 1976-11-10
IE39495L (en) 1974-12-14
JPS5035160A (sv) 1975-04-03

Similar Documents

Publication Publication Date Title
NO145273C (no) N-formyl-alfa-l-aspartyl-l-fenylalanin for anvendelse til fremstilling av alfa-l-aspartyl-l-fenylalaninalkylestere
SE423631B (sv) Forfarande for framstellning av oxaalhyl-dialkylxantiner
SE412389B (sv) Forfarande for framstellning av 1-ftalazon-derivat.
SE7710599L (sv) Forfarande for framstellning av bensisoxazoler
SE7416195L (sv) Forfarande for framstellning av cefalosporiner.
SE411212B (sv) Forfarande for framstellning av 3-halogen-cefalosporiner
SE420604B (sv) Forfarande for framstellning av oxazolderivat
NO146596C (no) Fremgangsmaate for fremstilling av 6-deoksytetracykliner
SE7712151L (sv) Forfarande for framstellning av linkomycinderivat
SE417601B (sv) Forfarande for framstellning av amidinokarbamider
NO790627L (no) Fremgangsmaate for fremstilling av hydroksyalkylxantiner
NO153806C (no) Fremgangsmaate for fremstilling av 6-deoksytetracyklin.
SE408709B (sv) Forfarande for framstellning av indol-, resp azaindol merkatoforeningar
SE420716B (sv) Forfarande for framstellning av nya 2-aminometyl-4,6-diahalogenofenolderivat
AR206610A1 (es) Procedimiento de preparacion de 2-metoxi-5-sulfonil(sustituidos)-benzamidas-(-sustituidas
SE7608956L (sv) Forfarande for framstellning av 2-(fenoxialkyltio)-5-nitroimidazoler
SE398120B (sv) Forfarande for framstellning av 3-(1-piperazinylalkyl)-2,4-kinazolindionforeningar
SE409994B (sv) Forfarande for framstellning av amidinokarbamider
SE411211B (sv) Forfarande for framstellning av 3-halogencefalosporiner
SE7613500L (sv) Forfarande for framstellning av cefemderivat
DK137452B (da) Analogifremgangsmåde til fremstilling af disubstituerede azabicycloalkaner.
SE401835B (sv) Forfarande for framstellning av 17beta-hydroxi-16,16-dimetylest-4-en-3-on
SE407219B (sv) Forfarande for framstellning av metyl-3-(2--kinoxalinylmetylen)-karbazat-nŸ1,nŸ4-dioxid
NO144018C (no) Fremgangsmaate for fremstilling av heterocykliske forbindelser
NO139479C (no) Fremgangsmaate for fremstilling av 4-amino-3,5-dihalogen-fenyl-etanolaminer